MD: Jordan University of Science and Technology, 2004
Residency: Pediatrics, University of Nebraska Medical Center, Omaha, NE, 2010
Fellowship: Pediatric Hematology Oncology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2013
Fellowship: Sickle Cell Scholar, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2014
Certifications: Pediatrics, 2010; Pediatric Hematology/Oncology, 2015
Pediatric hematology; sickle cell disease; hemoglobinopathies; congenital anemias; immune mediated cytopenia
Cardiopulmonary complications of sickle cell disease; congenital anemias
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Characterizing Engagement With a Mobile Health Application Designed for Adolescents and Young Adults With Sickle Cell Disease: Findings From the COMETS Study. Pediatric Blood and Cancer. 2026; 73(6):e70252.
Recruitment and retention of young adults with sickle cell disease. Health Care Transitions. 2026; 4:100133.
Community health worker support to adolescents and young adults with sickle cell disease: A multi-method analysis on transition-related support. Health Care Transitions. 2026; 4:100137.
Longitudinal changes and predictors of cardiac extracellular volume fraction in sickle cell anemia. Blood Red Cells Iron. 2025; 1(3).
A New First-Line Option for Pediatric ITP-Incremental Progress or Paradigm Shift? Journal of the American Medical Association (JAMA). 2025; 334(20):1802-1803.
Community Health Worker and Mobile Health Interventions for Quality of Life Among Young Adults With Sickle Cell Disease: A Randomized Clinical Trial. JAMA Network Open. 2025; 8(11):e2543571.
Reassessing voxelotor safety and efficacy: Real-world outcomes from the ASH research collaborative data hub. Blood. 2025; 146(Supplement 1):6226-6226.
Impact of disease genotype and severity of anemia on myocardial extracellular volume fraction in sickle cell disease (SCD) and non-SCD hemolytic anemias. Blood. 2025; 146(Supplement 1):2957.
Congenital dyserythropoietic anemia type I: Updated report from the congenital dyserythropoietic anemia registry of North America. Blood. 2025; 146(Supplement 1):4685-4685.
Biomarkers of ineffective erythropoiesis in patients with transfusion- dependent thalassemia. Blood. 2025; 146(Supplement 1):4684-4684.
Omar Niss, MD, Punam Malik, MD4/15/2020
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey